|
2019
|
Invention
|
Dosing regimens of pkc activators. Dosing regimens and methods are disclosed for upregulating pro... |
|
|
Invention
|
Pkc-activating compounds for the treatment of neurodegenerative diseases. The present invention r... |
|
2018
|
Invention
|
Methods of stimulating cellular growth, synaptic remodeling and consolidation of long term memory... |
|
|
Invention
|
Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced... |
|
|
Invention
|
Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurode... |
|
2017
|
Invention
|
Compositions and methods to treat niemann-pick disease. The present disclosure is directed to com... |
|
2016
|
Invention
|
Dosing regimens of pkc activators.
Dosing regimens and methods are disclosed for upregulating on... |
|
2015
|
Invention
|
Methods for alzheimer's disease treatment and cognitive enhancement. The present invention relate... |
|
2012
|
Invention
|
Esters of dcpla and methods of treatment using the same. The present disclosure relates to esters... |
|
|
Invention
|
Pkc activators and combinations thereof. The present disclosure relates to PKC activators and com... |
|
2011
|
Invention
|
Treatment of cognitive disorders associated with abnormal dendritic spines using pkc activators. ... |
|
2004
|
Invention
|
Methods for alzheimer's disease treatment and cognitive enhance.
The present invention relates t... |
